• FBB December 2018 – Newsletter

    December 2018 – Newsletter
    This month of December will beautifully close 2018 with 2 featured companies:
    Aspen Biosciences, who is launching a new comprehensive tool for a through exploration of the Biotech market, called Pharm2Market.
    And the in Vivo division of PerkinElmer, with the IVIS in vivo imaging systems and Quantum microCT imaging systems, which are best in class preclinical instruments for robust translational research.
    Companies of the month
    Aspen Biosciences

    Résultats de recherche d'images pour « Perkinelmer »
    Aspen Biosciences – Pharm2Market

    Aspen Biosciences is a research informatics company which provides software and services to support drug discovery organizations. Some of our previous projects include custom target-, assay-, and compound-management systems designed to meet the unique needs of our customers. We also provide technology selection and implementation services for electronic lab notebook (eLN), and Lab Information Management Systems (LIMS). We have experience implementing systems to support a variety of therapeutic classes including small molecule, antibodies & peptides, and cell-based therapeutics.
    Pipeline – Drug Discovery Portfolio & Project Management
    Over the years we’ve had frequent requests for help developing or integrating project management tools. The challenge for most pharmaceutical companies has been that off-the-shelf applications in this space lack direct support for the science behind drug discovery projects. Tools like Microsoft Project, Jira, SmartSheet, and Asana lack support for target, pathway and literature information. They have no support for meeting and decision tracking, and lack support for lessons learned. To address that, we’ve distilled conversations with dozens of project and scientific portfolio managers in biotech and pharmaceutical companies into a cloud-based application called Pipeline.
    Pipeline helps drug discovery companies answer questions like, “What drug targets and pathways are we working on”, “What is their role in a given disease”, “What recent discoveries have been made (literature searching)”, “Who’s working on the project (project tracking & dashboarding)”, “What tasks are they performing”, “What’s the current status of the project”, “Where are the results from that cell-based assay we screened last month”, “How is this project similar to the project we worked on 5 years ago”, “What did we learn from this project”, “What lessons did we learn from previous projects that we can apply to this project”.

    Pharm2Market – Connecting Drug Discovery Communities
    Pharm2Market is a new service that we’re launching to connect drug discovery startups to news, investors, partners and services to help advance their drug discovery programs.
    If you’re a founder, Pharm2Market can help you find investors, partners and services in your area. We also help you find the resources, everything from finding legal advice on company formation and IP, to finding lab space, lab instrumentation and reagents. We also connect you with resources like the French Bio Beach, and San Diego Venture Group to help expand your network and keep track of all the local networking and conference opportunities.
    If you’re a business development professional, Pharm2Market contains information on over 200 local drug discovery companies. We track the projects, targets, therapeutic areas and therapeutic classes, pathways, and clinical trials that companies are involved in. This makes it easier for you to identify potential partnering and licensing opportunities.
    If your company provides lab space, construction or facilities services, you can use Pharm2Market to identify companies in need of expanded lab space, or lab remodels. If you provide contract research or manufacturing services, Pharm2Market can help you identify customers with Phase 2 and 3 projects who need your services in order to complete their clinical trials.

    To learn more about us or start a conversation, visit us on our web site, or reach out to us on social media:
    Twitter: @AspenBio @Pharm2Market
    Email: info@aspenbiosciences.com


    PerkinElmer In Vivo Imaging
    Image Caption: “IVIS Spectrum 3D bioluminescence reconstruction shows precise localization of GL261-luc2 brain tumor using digital organ map.”

    PerkinElmer Inc, through its Discovery & Analytical Solutions business segment, provides a suite of in vivo imaging solutions (IVIS) comprising reagents, software and instrumentation.  This powerful suite of tools allows researchers to visualize cellular and biological functions as well as anatomical and physiologic changes non-invasively in whole, live animals. 

    Optical imaging
    PerkinElmer’s IVIS instrument platform boasts several models each with somewhat different features and benefits and each designed to fit within almost any research budget.

    PerkinElmer’s flagship IVIS instrument is the IVIS Spectrum.  The Spectrum is the most advanced optical imaging system on the market combining high throughput (2D) optical imaging and full tomographic (3D) optical imaging in one platform.  The IVIS Spectrum is capable of ultra-sensitive bioluminescent and fluorescent imaging.  Bioluminescent sensitivity is achieved by using a cooled (-90ºC) camera with large CCD chip area and low F-stop.  With an exquisite signal-to-noise ratio (SNR) better than any other instrument on the market, the IVIS Spectrum has even been shown capable of detecting as few as five cells subcutaneously in nude mice.  For fluorescence applications, the IVIS Spectrum employs an optimized set of high efficiency filters (400nm to 900nm) and patented spectral unmixing software algorithms which grant researchers the ability to image and quantify all commonly used fluorophores, including fluorescent proteins, dyes and conjugates. 
    Going beyond just 2D imaging, full tomographic (3D) optical imaging can also be achieved with the IVIS Spectrum.  This allows researchers to analyze 3D sources in an anatomical context and quantify the of number of cells and/or the dye concentration.  Additionally, the 3D optical data can be co-registered with other tomographic technologies such as MR, PET or CT through PerkinElmer’s LivingImage multimodality software module.
    MicroCT Imaging
    Preserving the historical sweet spot of microCT imaging, PerkinElmer’s Quantum GX2, is an excellent imager for studying bone in exquisite detail.  But, thanks to its unique flat panel CMOS detector and its cardiac and respiratory gating tools, the Quantum GX2 also excels at providing functional information, such as cardiac function estimation or perfusion, as well as other soft tissue applications.
    Image Caption: “Quantum GX2 image of a mouse heart scanned using a four minute gated scan with CT contrast.”
    As previously mentioned, microCT has historically and primarily been used as a tool for capturing bone and skeletal image data, but bone data analysis was tedious and cumbersome.  To rectify this, scientists at PerkinElmer built AccuCT—a one-of-a-kind advanced, automated bone analysis software tool.  Designed to automatically segment bones and perform ASBMR morphometric analysis, AccuCT enables researchers at all levels of experience to perform advanced bone analysis in a user-friendly workflow-based software package.  In addition to facilitating data analysis, AccuCT’s 3D rendering capabilities produce high impact images for manuscripts and presentations with just a few mouse clicks. 
    Image Caption: “AccuCT from PerkinElmer automates bone identification, segmentation and analysis.”
    Through its advances in optical imaging and innovation with microCT imaging, PerkinElmer continues to open new doors for academic researchers and industry scientists alike.  Optical image data and microCT data can even be co-registered to better understand disease nuances in all its dimensions.
    To learn more about how in vivo imaging can help advance your research please contact your in vivo imaging specialist, Marc Guerra, at (619) 302-8405 or marc.guerra@perkinelmer.com

    Next Breakfast Event
    Because you are already sweet enough!
    Considering the significant increase of sugar consumption and commitments during the period of Christmas and New Year, the FBB committee board will hold on the Breakfast networking event until February.


    Happy Hour Networking Event
    bella vista social club & caffe
    December 14th
    from 5pm to 7pm (PST)
    Celebrating the end of the year. Come to tell us about your 2018 achievements and plan your 2019 expectations with a drink together.
    Social Activity
    Last chance to get your voice heard if you want to promote your favorite activities.
    First round of activity would open on Sunday, January 20, 2019 (10am-12pm).
    For now, six activities are leading the way: Hike, Surf, Pool (billiard), SUP/Kayak, Snorkeling, Tennis.


    Local News/Events
    Professional opportunities
    Antibody Design Labs is recruiting!
    We are looking for a part-time Office Assistant at our new location. The person will be in charge of diverse office clerk duties including helping with shipping and receiving, ordering and maintaining supply, managing files, recording information, greeting clients and visitors and coordinating team work and communication, among others. A strong organizational skill is welcome.
    Please send inquiry with resume at:  support@abdesignlabs.com
    We wish you happy holidays and hope to see you at our events!
    Kevin Adam, Beatrice David Shevlin and Stephane Richard of the French BioBeach team
    Follow our events and share to your friends/colleagues


    Thank You to our SPONSORS
    Résultats de recherche d'images pour « Perkinelmer »

    Copyright © French BioBeach, All Rights Reserved.
    Business Platform, San Diego Area, California, United States
    Don't want this? Click here to unsubscribe.
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com
  • FBB November 2018 – Newsletter

    November 2018 – Newsletter
    After a month of October rich in networking events, November is following with the same momentum. Here are our news and activities for the upcoming month. In November our featured company is Cypre.
    Company of the month
    Cypre, Inc. has developed a simple 3D cell culture platform and tested protocols enabling scientists to assay complex tumor biology, including ex vivo (patient, PDX, mouse), tumor-stromal and tumor-immune coculture studies.


    VersaGel® is our proprietary, biocompatible 3D matrix that has the benefits of a hydrogel with the functional relevance of an extracellular matrix (ECM). Its design allows for cellular adhesion (through integrin binding sites, e.g. RGD), tumor and immune cell invasion, and MMP-degradation, mimicking the multiple phases of tumor progression.  VersaGel-Immunology is optimized for immune cell infiltration assays and VersaGel-Oncology, used in solid tumor assays, comes in three formulations for different growth conditions of various tumor cell types – Soft, Standard, Stiff. VersaGel is amenable to various methods of analysis, including high content imaging, plate reading, and flow cytometry following a 30-minute matrix digestion.
    Symphony® is our patented one-button instrument that solidifies VersaGel in microwell plates in 60 seconds. Symphony-24 and Symphony-96 are specifically designed for 24-well and 96-well plates respectively. Not much wider than a microtiter plate, the Symphony’s small footprint allows it to easily fit in your bio-safety cabinet further streamlining your workflow.
    Contact Robert Lynde (robert@cypre.co) to learn more about our demo program.
    Copyright© 2018 Cypre, Inc. All rights reserved.

    Next Breakfast Event



    Join us for a casual breakfast. This month Abbiotec will host the event. Abbiotec offers years of expertise making antibodies and assay kits for catalog products to the scientific and biotech community.
    When? Wednesday, November 7th
                from 8:00 to 9:30 am (PST)
    Where? 7985 Dunbrook Road,
    Suite A – San Diego, CA 92126

    Contact : (858) 586-0500  

    Happy Hour Networking Event
    bella vista social club & caffe https://ecp.yusercontent.com/mail?url=https%3A%2F%2Fcdn.evbuc.com%2Feventlogos%2F31248%2Fbellavista-2.jpg&t=1540866915&ymreqid=6ccb5610-53a0-1f6f-1c20-110001011c00&sig=unkBVS2esapgtA5MkKNLYg--~C
    November 9th
    from 5pm to 7pm (PST)
    Celebrating the Movember. Bring your most beautiful mustache to soak it in a drink together.
    All pattern are welcome!
    Social Activity
    Give us your opinion!
    The FBB community is growing and even if our common interests does not change, our way to interact can evolve. So let`s consider some activities together.
    Special Event
    Saturday, November 10th
    San Diego Fall Regatta 2018 – Sponsored by CureMatch
    If you wish to take advantage of this annual event to communicate/advertise about your company, we are currently open to distribute some goodies on the day of the event. Please contact the FBB Board of directors for any participation.
    Local News/Events
    We wish you a happy Halloween and hope to see you at our events!
    Kevin Adam, Beatrice David Shevlin and Stephane Richard of the French BioBeach team
    Follow our events and share to your friends/colleagues




    Thank You to our SPONSORS
    Résultats de recherche d'images pour « Perkinelmer »


    Copyright © French BioBeach, All Rights Reserved.
    Business Platform, San Diego Area, California, United States
    Don't want this? Click here to unsubscribe.
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com
  • FBB October 2018 – Newsletter

             French BioBeach October 2018 – Newsletter

    Our newsletter keeps you in the loop of FBB’s News & Events. If for any reason you would like to  
    You are welcome to join us again at a later time
    ~~ French BioBeach Breakfast ~~
    Start October with the traditional French BioBeach Breakfast sponsored jointly by ODEXXO! Network with Biotech professionals in a casual and warm atmosphere, while croissants and coffee will be graciously served:
    When?        Wednesday, October 3rd 2018 
                       from 8:00 to 9:30 am
    Where?      6450 Lusk Blvd, Suite E100
                       San Diego, CA 92121 
    Contact :    (858) 525-2318 
    About ODEXXO and its Founder
    ODEXXO Inc. designs proprietary portable devices for biological specimen collection and in-vitro diagnostic testing, based on immuno-chromatographic lateral-flow assays. The company’s All-in-One Platform offers optimal Ease-of-Use, Convenience and Safety.
    Physicians and Veterinarians around the world have relied on ODEXXO’s Technology to perform Multi-Disease Diagnosis within Minutes in challenging environments, such as at remote Point-of-Care, on the Farm or in the Field. 
    Phuong Nguyen, MBA, is the company’s Founder and CEO.  She has extensive experience launching novel products in the US and European markets, and continuously strives to bring innovations to serve the IVD community.

    Kevin Adam, Beatrice David Shevlin and Stephane Richard of the French BioBeach team, with Phuong Nguyen (CEO of ODEXXO) look forward to seeing you!
    Or just show up!

    ~~ French BioBeach Company of the month ~~ 

      PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of about 11,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics and discovery and analytical solutions markets.
    PerkinElmer’s comprehensive portfolio of technologies helps life sciences researchers better understand diseases and develop treatments.
    Scientists and clinicians can gain biological insights to improve outcomes through our discovery instruments and reagents, quantitative pathology platform, informatics software and lab services. 
    Our technologies and expertise have been instrumental in the development of 22 of the newest therapeutic drugs. 
    PerkinElmer’s Operetta CLS™ high-content analysis system enables scientists to uncover deep biological understanding from everyday assays and innovative applications. The system features a unique combination of technologies to deliver the speed, sensitivity and resolution needed to reveal fine subcellular details.
    The Opera Phenix™ high-content screening system is designed for high-throughput phenotypic screening and cellular analysis and is ideal for complex disease models such as live cells, primary cells and 3D cell culture models.
    Find out how PerkinElmer high-content analysis solutions allow robust and predictive discovery by visiting:

    Your West Coast High Content Imaging contact at PerkinElmer is Beatrice David Shevlin: beatrice.davidshevlin@perkinelmer.com
    858 603 2233
    ~~ French BioBeach Happy Hour ~~


    Monthly Happy Hour @ Bella Vista
    Join us for our Happy Hour! Let's enjoy a nice beer or a glass of wine (or both!) Come on! Let's get together:)
    We look forward to seeing you there…!
    When?    Friday, October 12th
                   from 5:00 to 7:00pm

    Free (no host bar)
    & open to all
    or just show up 🙂
    Thank You to our  Partners


    Big Thank You to our Sponsors & Members
    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com


  • FBB September 2018 – Newsletter

             French BioBeach September 2018 – Newsletter

    Our newsletter keeps you in the loop of FBB’s News & Events. If for any reason you would like to  
    You are welcome to join us again at a later time

    What`s going on at the FBB?

    Introduction of Kevin Adam, PhD and Beatrice David Shevlin, PhD, Co-directors of the French BioBeach business platform

    After Clementine Gibard beautifully took care of the French Biobeach activities and left for Idaho in January 2018, Stephane Richard is now working with two new team members, Kevin Adam, representing the more academic wing of the platform, and Beatrice David Shevlin, with industrial experience.

    Thank You to our  Partners


    Kevin Adam, PhD

    Native from Brittany on the west coast of France, Kevin joined the warmer west coast of the US in September 2015. With over 7-years of experience in project management & research/development and over 2-years’ experience as consultant in competitive intelligence & market research, he joined the direction of the French BioBeach in 2018. Holder of a Master`s dual-degree in Oncology from the Ecole Normale Superieure of Cachan and a Magistere of Biotechnology from the Paris-Sud University (Paris XI), he earned his PhD in Onco-hematology from the Paris-Descartes University (Paris V) as a biologist.

    While doing his PhD, Kevin joined in 2012 the business incubator Quattrocento (5th French Tech investment) as a consultant in R&D strategy and innovation to satisfy his interest in innovation and industrialization. Then, he participated to the launch of the educational program Savanturiers in 2013, advertised later through the TEDx talk in Paris, to promote learning through experimenting and communication.

    Currently research associate at the Salk Institute, professional scientific collaborator at The Scripps Research Institute and consultant fellow at the APDCC of UCSD since 2016, he is now intending to expand the French BioBeach network and community. During the rest of his time, Kevin enjoys the outdoors activities offered by the Californian weather and he is fervent of backpacking adventures and travels.


    Beatrice David Shevlin, PhD

    Beatrice owns a double master’s degree in Organic Chemistry and Pharmacology, after completing the “Magistere Chimie-Biologie” at Louis Pasteur University, Strasbourg, France, and a PhD in Bio Organic Chemistry from Louis Pasteur University (January 1995), prepared under the supervision of Dr Francis Schuber.

    After a post doc at Kyoto University, Japan, she soon moved to business after earning a Purchasing Manager degree from IFOCOP Paris. She worked as a procurement associate for Clariant, in the Cuise-Lamotte factory, North of Paris.

    From 1999, Beatrice has been perfecting and selling scientific imaging platforms, to academic and industrial research laboratories, first with Hamamatsu Photonics France, then in 2004, she started and optimized the European branch of Xenogen Corporation, a San Francisco Bay based company that pioneered pre-clinical molecular imaging using bioluminescence and fluorescence. Xenogen Corporation was subsequently acquired by Caliper Life Sciences, which became part of PerkinElmer in 2011.

    In 2014 she moved to San Diego, and, after developing the sales of IVD devices in Europe for Acon Laboratories. She returned to PerkinElmer in January 2016 to become PerkinElmer High Content Imaging Senior Sales Specialist for the West Coast.

    Joining the French BioBeach is a natural move.

    Beatrice has been conducting business since 1999 in 4 different languages (French, English, Spanish and Italian), and has good knowledge of the Japanese culture.

    In parallel Beatrice is deeply involved in San Diego’s dancer’s community.

    Big Thank You to our Sponsors & Members

    Come and meet the new team on September 14, at 5 PM, at the French BioBeach happy hour at the Bella Vista Caffe.


    Upcoming French BioBeach Events

    Monthly Happy Hour @ Bella Vista



    End of the week, Sunset & Happy Hour After Work? Let’s get together for our Monthly Networking Happy Hours. 
    We look forward to seeing you there…!
    When? Friday, September 14th, from 5:00 to 7:00pm

     Where?  Bella Vista Social Club & Caffe, 2880 Torrey Pines Scenic Dr, La Jolla, CA 92037 

    Look for our French BioBeach sign!
    Whether you would like to come debrief recent events or come discuss your latest startup project, the needs of your company (funding, advisors, people, CRO, IP attorney …), your latest scientific discovery (that you have of course already covered by a provisional), or just grab a TGIF drink and a glimpse of the sunset over the ocean with a bunch of international men & women of the San Diego biotech community, come join us at Bella V. .. and don’t worry, you don’t have to be French or speak French …






























    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com


  • FBB November 2017 Newsletter

    Our newsletter keeps you in the loop of FBB’s News & Events. If for any reason you would like to  
    You are welcome to join us again at a later time


    Thank You to our  Partners



    Big Thank You to our Sponsors & Members




    French BioBeach November 2017 Newsletter
       Dear French BioBeach community,
    After the success of the last month beakfast at Antibody Design, we are pleased to welcome you TOMORROW (Wednesday 1st) at ABBIOTEC jointly sponsored by ODDEXO. 
    To start this exciting newsletter we will present our FBB events with the traditional networking opportunities –> the Breakfast and the Happy Hour rendez-vous.
    Because to work hard we need to play hard sometimes, our new member SOMMAILLIER will present his concept of wine imported from France in the company of the month section, with an exclusive FBB discount just for you 🙂
    We end this newsletter by some events and news we thought you might enjoy!
    Thanks to your support, we continue to monitor what happens in the Life Sciences community fostering new Partnering and Business Opportunities.
    The French BioBeach Team  Cool
    Upcoming French BioBeach Events
    Coffee & Croissants
    The FBB Breakfast were traditionally on the first Tuesday of the month, but we thought that hump day will work even better!
    So from now on, you are welcome to join us on the first Wednesday of the month to share the yummy croissants and the much needed morning coffee 🙂
    When? Wednesday, November 1st from 8:00 am to 9.30 am


    Where?  Abbiotec  | 7985 Dunbrook Road | Ste A, San Diego | CA 92126


    Monthly Happy Hour @ Bella Vista

    End of the week, Sunset & Happy Hour After Work? Let’s get together for our Monthly Networking Happy Hours. 
    We look forward to seeing you there…!

    When? Friday, November 10th, from 5:00 to 7:00pm


    Where?  Bella Vista Social Club & Caffe, 2880 Torrey Pines Scenic Dr, La Jolla, CA 92037 

    Look for our French BioBeach sign!


    Free (no host bar)
    & open to all

    or just show up 🙂

    Whether you would like to come debrief recent events or come discuss your latest startup project, the needs of your company (funding, advisors, people, CRO, IP attorney …), your latest scientific discovery (that you have of course already covered by a provisional), or just grab a TGIF drink and a glimpse of the sunset over the ocean with a bunch of international men & women of the San Diego biotech community, come join us at Bella V. .. and don’t worry, you don’t have to be French or speak French …


    Company of the Month
    SOMMAILIER : a wine club created through 5 generations of French wine making experience
    For this month featured “company of the month”, we’d  like to introduce a newly created company here in San Diego,  SOMMAILIER! This is not yet another new microbrewery but   instead a brand new kind of boutique wine club 100% dedicated to French wines created by San Diego local and Bordeaux-native, Laurent Yung. He comes from five generations of French winemakers and has  access to exclusive, boutique French wines through his many connections in France. That’s the reason he started Sommailier – to share exclusive handcrafted wines that you can’t find in the U.S. with people who love French wine or want to learn more about it. Best part? The wine is shipped directly to your door every three months! And you can also send it as a gift to your wine lover friends or colleagues.Members will not only receive the bottles, but they will also receive education and information. Each bottle comes with a wine card providing information about the region it was grown and sourced, and the food pairing to accompany it. 
    Learn more about Sommailier and Laurent’s authentic story at www.sommailier.com. If you are interested in joining his club, you can use the code Biobeach20 and benefit from $20 off and free shipping on your first order. Feel free to contact him directly as well at laurent@sommailier.com if you have any question about his wine club.

    CRO Networking Mixer
    Please join on in the McGraw Boardroom at Biocom for a hosted CRO Networking Mixer specially designed for our CRO Members. With over a hundred CRO’s in our membership, this is an opportunity to gain a better understanding of your colleagues expertise in order to foster more collaboration within the CRO Community. 

    When?   November 7th 2017 5:00 pm to 7:00 pm
    Where? BIOCOM – McGraw Boardroom                            
    10996 Torreyana Road Suite 200
    San Diego, California  92121


    JLABS San Diego

    Meet with… Dementia Discovery Fund (DDF)
    Dementia is arguably the greatest single global healthcare challenge, affecting more than 47 million people worldwide at an estimated annual cost to the global economy of over US $604 billion…

    When? Tuesday, November 14th |
    10:30 AM to 5:00 PM
    Where? CONNECT
    4790 Eastgate Mall #125
     San Diego | California 92121       


    BioLabs San Diego 

    “Bubbly and Blowouts”


    Join at the new drybar in La Jolla. This is a great event to network with other women in tech and biotech. Space is limited so book your spot and get your tickets.


    When?  Tuesday November 14th 2017

    4:00 PM – 7:00 PM


    Where?  Drybar La Jolla

    8867 Villa La Jolla Drive
    La Jolla, CA 92037                                


    In the News
    • Thermo Fisher Scientific Signs Oncology Companion Diagnostic Development Agreement with Blueprint Medicines 
      MabVax Therapeutics Provides Update on the MVT-5873 Phase 1 Clinical Program and Expansion of Preclinical Development Pipeline at the AACR-NCI-EORTC International Conference
      Biotech Briefing: UC San Diego, Salk Scientists Awarded NIH Grants
    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com


  • FBB Monthly Croissants & Coffee Networking Breakfast




    ~~~French BioBeach BREAKFAST!!!~~~

    Monthly Breakfast

    Start November with the traditional French BioBeach Breakfast sponsored jointly by Abbiotec and ODEXXO!  Network with Biotech professionals in a casual and warm atmosphere, while croissants and coffee will be graciously served, at

    When? Wednesday, November 1st
               from 8:00 to 9:30 am


    Where? Abbiotec | 7985 Dunbrook Road Ste A, San Diego | CA 92126
    Contact : 858-586-0500

    or just show up 🙂
    ABBIOTEC offers years of expertise making antibodies and assay kits for catalog products to the scientific and biotech community. With our recently upgraded animal facility, we offer polyclonal antibody production in small and large animals (rabbits, goats, llama) as well as monoclonal antibody production (mice and rats). Because peptide chemistry is an essential tool to biology, we offer custom peptide synthesis services for research-grade peptides.
    ODEXXO designs and markets proprietary disposable devices for biological specimen collection and IVD rapid testing, based on immuno-chromatographic assays.  ODEXXO’s self-contained and multiplex systems offer the optimal convenience and safety for veterinarians and physicians in a point-of-care, farm or field setting.
    Clémentine Gibard and Stephane Richard of the French BioBeach team, Phuong Nguyen (CEO of ODEXXO) and Herve le Calvez (CEO of Abbiotec) look forward to seeing you!
    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com


  • Biocom in France: Part Deux

    Franco-American biotech ties flourish

    By Joe Panetta11:55 A.M.MAY 4, 2015








    San Diego delegation and PACA partners outside the offices of Innate Pharma. — Biocom

    (Editor's note: This is Part 2 of Biocom CEO Joe Panetta's return trip to southeastern France with a delegation from Biocom and French BioBeach, to strengthen the partnership between the region and Southern California. You can read Part 1 of the trip to Provence-Alpes-Côte d'Azur, or PACA, here)

    For two days since arriving here in Marseille to continue our Biocom and French BioBeach delegation trip, we have been awed by the growth of this life science cluster within the second largest city in France. We have visited clinical research hospitals and life science parks, an incubator and biotech companies including one that has been quite successful, as well as met with regional political and business leaders and potential partners.

    It has been a whirlwind two days in which our hosts and Biocom partners – Eurobiomed and the South Bio Alliance – have gone to extraordinary lengths to extend their hospitality and a unique perspective on all that this region can offer in the life sciences arena.

    We began yesterday with a visit to the Luminy campus of Marseille Immunopol, the subcluster for immunology in Marseille. It has unique positioning for immunology as a key technology here and has created an alliance that brings together all of its stakeholders within a collaborative ecosystem for innovation in immunology. The Immunopole includes hospitals, research institutes, academic labs and biotech companies.

    Marseille has a 40-year history of discovery and development in immunology beginning with Beckman Coulter Innotec which led to 60 spin-offs and other start-ups such as Innate Pharma, now a very successful company that we visited within the Immunopole. Innate has raised $185 million and has completed $1.8 billion in deals since 2006 including its most recent with AstraZeneca worth $250 million in initial payment with milestones worth up to $1.3 billion.

    A second company that we talked to was HalioDx, a spin-off of Qiagen Marseille that has a unique biomarker portfolio for use potentially by large pharma in developing companion diagnostics.

    Also within the Luminy Park is the Association Grand Luminy, the sole biotech incubator in the south of France which has operated since 1985. It has 2 missions: to sustain the local economy and to create and grow companies. Since 2009 Grand Luminy has also run a Biotech Nursery to host start ups from the incubator within a structure that includes support services, an entrepreneurship manager, strategic partnership development, patenting, communications management and corporate identity.

    To obtain a better understanding of the ability of the Marseille cluster to conduct clinical trials we visited AP-HM, the 3rd largest university hospital in France built on the concept of combining a high-technology hospital with research training. The hospital is now running more than 300 clinical trials.

    The day ended with expert presentations on human resources management, drug regulation in France and company financing at the 400-year old Palais de la Bourse, which is now home to our hosts for the afternoon and evening, the International Chamber of commerce of Marseille.

    The leaders of the Regional Council, Stephane Richard of French BioBeach and I exchanged greetings and addressed guests representing life science companies, the media and business leaders followed by a networking event held to welcome our delegation. While the event lasted well into the evening we knew that we could not end the day in this great city without once again sampling the remarkable bouillabaisse that is so expertly prepared within a few great establishments here, and at 10 PM in the evening we descended upon Le Rhul Restaurant. By midnight we were satiated and exhausted, and returned to our hotel.

    Today's schedule began even earlier in the morning with a visit to the IPC Paoli Calmettes cancer treatment center. It is one of a group of cancer treatment and research centers created by the great French President Charles de Gaulle after World War II, of which there are 20 in France.

    IPC Paoli is unique in that it includes a new unit called IPC Drug Discovery which works primarily in technologies that can detect blood levels of antibodies in an attempt to better identify weaknesses of cancer cells and DNA repair mechanisms. It also has a strong epigenetics group and a group working on metastasis. The unit is trying to find partners in pharma and biotech to conduct Phase I trials and to establish start up companies.

    Investment funding is available in Marseille as we learned in a presentation on PACA Investissmente, which sponsors a capital investment fund of 19.45 million Euro,managed by Thurenne Capital. Since its first investment in 2011, it has made investments in 38 companies and created 32 partnerships in the PACA region. To apply for funding a company must be early stage and incorporated in the region.

    This trip would not have been complete without a visit to NeuroService, a contract research firm located outside Marseille in Aix-en-Provence. The company has ties to San Diego as the region's first Biocom member firm here, and does 60 percent of its business in the US. NeuroService specializes in pharmacological assays based on electrophysiological recordings of acute brain and spinal cord slices, and cultured neurons to support early phases of CNS and pain R&D programs.

    Our second long day in the region ended with an informative tour of Aix-en-Provence city center and a farewell dinner with our most cordial hosts. It has been a truly incredible visit here from the standpoint of experiencing just how similar this area is to San Diego in its life science collaboration, diversity and innovation.

    A two-year gap in visiting our partners here perhaps provided a better perspective on their progress, but we talked over dinner about the opportunity to work together more closely in the future as the bridge we are building attracts more traffic.


  • French biotech: A return visit

    Biocom delegation travels to southeastern France for biotech

    By Joe Panetta12:05 P.M.

    Officials of San Diego's Biocom and Eurobiomed, an agency in southeastern Francce, sign an agreement to help biotech companies do business in each other's regions. From left, Magda Marquet, founder of Althea Technologies and chair of Biocom; Jacquie Berthe, president of Eurobiomed and a scientific director of Sanofi-Aventis; and Joe Panetta, president and CEO of Biocom.

    (Editor's note: Biocom, the San Diego-based life science trade group, has long cultivated ties with biotech in other nations. Biocom CEO Joe Panetta describes the group's latest mission, a return trip to France.)

    Two years ago I reported to U-T San Diego readers on the first trip by Biocom, French BioBeach and our members to Nice and Marseilles to explore partnership opportunities between life science clusters in the two regions of southern California and the Cotes d'Azur/Provence. That visit was eye-opening for all of us who participated, as we gained a great appreciation for the entrepreneurial environment and the long history of life science company formation and success, as well as the standout experience here is the conduct of clinical trials for oncology products.

    The relationship was furthered last year as representatives of both regions including Biocom, French BioBeach, and what is now known as the Provence-Alpes-Cote d'Azur South Bioalliance

    signed a formal partnership agreement during the BIO 2014 convention in San Diego.

    We returned to Nice and Marseilles in the spirit of our formal partnership this week with some past participants from San Diego, including Biocom Board Member and lead patent counsel at WSGR, Jeffrey Guise, Mike Honeysett of Acea and me, as well as new delegates such as the CEOs of Flow Paradigm, OncioMed, Abreos Biosciences (with one of his scientists) and CVAC Systems – a very inquisitive and engaged group who have asked probing questions of our hosts here while thus far expressing enthusiasm about what we have seen on the first part of our trip in Nice.

    Here's an update on the state of life science in this region in 2015 to provide a bit of perspective and comparison with southern California.

    The industry here is represented by 400 companies employing 10,000 people. Leading companies here include Beckman Coulter, Galderma, Sanofi-Aventis and Nicox. It is France's second largest center for clinical trials with 30,000 doctors and 39,000 hospital beds. It is a center of convergence of biotechnology, aquatic technologies, IT and wireless communications and tourism, and it has 6 universities including the largest in France in Marseilles (if this all sounds familiar it is because it is a mirror image of San Diego).

    Two years ago I reported that what struck me most about this region is its advanced experience in the field of clinical medicine. This was reinforced yesterday on our visits to the Centre Antoine Lacassagne, a regional cancer center that is close to completing a synchro-cyclotron proton therapy device that is the first of its kind in Europe, and to the national Alzheimer's pilot Institut Claude Pompidou for a presentation of some leading research projects of non-drug therapies to enhance cognitive function in patients through the use of IT-based solutions.

    The device at Lacassagne is one-fourth the weight of previous devices and uses 1/8 the electricity with a new dose administration technology called PBS – pencil beam scanning which is intensity- modulated to provide much higher "conformation" to tumor shape than past devices.

    We followed up with presentations by lead scientific researchers at the Institute of Biology Valrose within the University of Nice Sophia Antipolis, an international research center that addresses fundamental topics in developmental biology with links to associated diseases such as cancer, diabetes and obesity and utilizing various scientific approaches such as genetics, cell signaling and integrative physiology carried out on a wide range of model organisms.

    The impressive presentations on human adipose stem cells and obesity, on generation of functional beta cells from alternative pancreatic cell subtypes, on a flow cytometry iBV platform and on experimental histology in development and disease drew comments and questions by our group regarding the competitive nature of the work with what is being done in San Diego.

    Our long day ended with all of our companies making quick pitch presentations to an invited group of Nice life science company representatives at the Team Cote d'Azur office.

    Today (Tuesday) began with a legal presentation on doing business in France by the FIDAL law group ( the most popular question being whether it is actually possible to terminate an employee in France) followed by a day of visits to some of Nice's leading life science companies.

    Two that were of particular relevance to our San Diego group were Integra Life which is a device company based in New Jersey and producing brain catherization and mapping products here, and TxCell which is developing T cell immunotherapies for severe chronic inflammatory and autoimmune diseases such as Crohn's Disease. The latter drew questions from the entire group because the technology was an area of familiarity to many of our participants but even more so because all agreed that the research rivaled what they had seen in immunotherapy product development in San Diego.

    Another long day ended with our transfer to Marseilles and a late-evening reception hosted by the Eurbiomed-Provence Promotion Team. We'll spend the next two days here in Marseilles further examining the many potential opportunities for our southern California companies.


  • 2014 Nov 15th – Life Sciences on the Bay

    Saturday November 15th 2014, San Diego Bay,

    from 12:00PM to 3:00PM. 1590 Harbor Island Dr, San Diego, CA 92101, Thank you for your support!


    “Life Sciences on the Bay”

    3rd Edition of the French BioBeach Fall Regatta,


    –> Pictures – BEST OF – Gallery of Cynthia Sinclair – Gallery of C.Cheung

    This year was a special year, as we did race for a cause, and dedicated this race to Alex. Our goal for this 3rd edition of the French BioBeach Fall Regatta, was to initiate our efforts to raise awareness for the undiagnosed children. This was not a fundraiser, it was a fun event to raise awareness.

    Who is Alex?

    DSC05309wIMG_1265w  Alex is a sweet 9 year old child who has endured 4 years of extensive medical tests and procedures that a child his age should not have to suffer. He was born a normal healthy baby, but in the course of the past 5 years a mysterious neurodegenerative disease has cruelly  robbed Alex of his ability to walk, stand, use his hands, speak and chew. He is wheelchair bound and completely reliant on others for his daily care. Though physically and verbally challenged, Alex remains remarkably cognizant. He developed uncontrollable and painful muscle spasms and recently experienced a seizure. As the disease continues to progress, we relentlessly push ahead in our search for a diagnosis so that we can begin the journey of seeking treatment for Alex.  Caroline Cheung (Alex’s mother)










    Here is a video about Alex

    Mystery Illness – Relentless Search continues from Caroline Cheung on Vimeo.

    Alex belongs to a category of patients called “Undiagnosed”

    There is a hidden epidemic – millions of people living with perplexing illnesses that elude definition and treatment. Undiagnosed: Medical Refugees is a medical documentary about what it is like to exist in a constant state of unknown, struggling with undiagnosed illnesses and rare diseases, and existing as medical refugees in a modern health care system. The film “Undiagnosed” aspires to bring objectivity to this controversial and timely subject by interviewing doctors, medical administrators, and people, both children and adults, who have the misfortune of suffering without a diagnosis. Research and professional opinions combine with gripping stories into an incredible narrative that showcases the strength of the human spirit and the need for change in our medical system.


    It was yet another beautiful day.


    310198_10151888293864338_1144467167_n Photos by Cynthia Sinclair

    The Fall Regatta is the last race of the CRA 2014 Hi-Point season, so you won’t want to miss it!




     CRAnewBrge1 CRATitle2

    Participating Companies:

    VertexPharma antibodydesignlabs     ODEXXO-logo_90   abbiotec

    logo-invivogen         logo (2)           edico-genome-logo  ebioscience-logo

    If you can not participate into the race, feel free to join Alex & the racers for the after race/trophy party that will take place, starting around 4PM at Fiddler’s Green Restaurant on Shelter Island

    fidbutn2Fiddler's Green SD


    Check out the pictures of previous editions

    of the FBB Fall Regatta

    – 2012 –

    – 2013 –


    Sail fast, race hard, be fair, have fun,

    and show your support to Alex.BioBeach_Logo-02 The Biotech Pirates




  • October 3rd 2014: San Diego Manufacturing Day Breakfast

    San Diego Regional Economic Development Corporation

    October 3 San Diego Manufacturing Day Breakfast

    Did you know there are over 3,000 manufacturers –
    supporting 93,450 jobs in San Diego County?

    October 3 is National Manufacturing Day. It acknowledges the great products made in your backyard and across the country. Over 20 San Diego manufacturers are opening their facilities throughout the day for tours to dispel myths about today's manufacturing and show the community the great career opportunities that are available within the industry.

    To kick-off the day's celebration, EDC along with sponsors and other community partners are hosting a breakfast event that will include remarks from Mayor Kevin Faulconer, City of San Diego, and Dr. Trudy Gerald, Dean of San Diego City College CACT program, acknowledging the importance of manufacturing in our region. A dynamic panel discussion will be moderated by Jack Stewart, President of California Manufacturers and Technology Association, and the panel will feature leaders from 3D Robotics, CareFusion, General Dynamics NASSCO, Sector 9, and ViaSat.

    Date: Friday, October 3, 2014
    Time: 8:30-10:30 a.m.
    Location: San Diego Central Library

    Register: https://sandiegomfgday2014.eventbrite.com
    Tickets: $25 if you register by Sept 19

    To host a tour, attend a tour, list of community partners, or for more information, visit http://www.sandiegobusiness.org/news/events



    Media Partner

    San Diego Regional EDC’s mission is to maximize the region’s economic prosperity and global competitiveness.

    For more information, please contact:
    Emily Moore
    Manager, Events